Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology
China Biotechnology  2020, Vol. 40 Issue (10): 112-121    DOI: 10.13523/j.cb.2006004
    
Bibliometric Analysis of Gene Research in Alzheimer’s Disease
LIU Yao-zhou1,MA Kai-yue1,WEI Hao-ran2,LIANG Teng-xiao1,XU Yuan-hao3,SONG Xiu-fang4,5,*()
1 College of Life Sciences, University of Chinese Academy of Sciences,Beijing 100049,China
2 College of Materials Science and Opto-Electronic Technology,University of Chinese Academy of Sciences, Beijing 100049,China
3 School of Chemical Sciences, University of Chinese Academy of Sciences, Beijing 100049,China
4 National Library of Sciences, Chinese Academy of Sciences, Beijing　100190,China
5 School of Economics and Management, University of Chinese Academy of Sciences, Beijing　100049,China
Download: HTML   PDF(39390KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Alzheimer’s disease is a progressive neurodegenerative disease with occult onset. With the global aging becoming more and more serious, Alzheimer’s disease is a serious threat to people’s health and quality of life. The causes of Alzheimer’s disease are complex, and the treatment of Alzheimer’s disease is still an important problem in medicine. In this paper, with the literature of Alzheimer’s disease gene research indexed in the core collection of Web of Science, bibliometric analysis of publication trends, researchers, institutions, countries and research hotspots was carried out to provide important reference for researchers in related fields.

Key words： Alzheimer’s disease      Bibliometrics      VOSviewer      Cooperation analysis      Cooccurence analysis     
Received: 03 June 2020      Published: 10 November 2020
ZTFLH:  Q819  
Corresponding Authors: Xiu-fang SONG     E-mail: songxf@mail.las.ac.cn
Service
E-mail this article
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
Yao-zhou LIU
Kai-yue MA
Hao-ran WEI
Teng-xiao LIANG
Yuan-hao XU
Xiu-fang SONG
Cite this article:

LIU Yao-zhou,MA Kai-yue,WEI Hao-ran,LIANG Teng-xiao,XU Yuan-hao,SONG Xiu-fang. Bibliometric Analysis of Gene Research in Alzheimer’s Disease. China Biotechnology, 2020, 40(10): 112-121.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.2006004     OR     https://manu60.magtech.com.cn/biotech/Y2020/V40/I10/112

Fig.1 The number of articles published in the Alzheimer’s disease gene research annually
Fig.2 Annual growth rate of the number of published articles on Alzheimer’s gene research
序号 发文作者 发文数量 发文时间范围 H指数 篇均被引 机构 国家
1 Hardy, John 126 1993~2020 55 132 伦敦大学学院 英国
2 Goate, Alison M 123 1995~2020 54 105 西奈山伊坎医学院 美国
3 Pericak-Vance, Margaret A 100 1991~2020 41 133 迈阿密大学 美国
4 Haines, Jonathan L 92 1992~2020 38 66 里尔大学 法国
5 Mayeux, Richard 92 1996~2020 41 67 哥伦比亚大学 美国
6 Schellenberg, Gerard D 84 1991~2020 41 56 宾夕法尼亚大学 美国
7 Tan, Lan 84 2008~2019 24 24 青岛大学 中国
8 Farrer, Lindsay A 83 1991~2020 38 69 波士顿大学 美国
9 Van Broeckhoven, Christine 82 1995~2020 42 110 安特卫普大学 比利时
10 Yu, Jin-Tai 79 2008~2019 24 25 复旦大学 中国
11 Morris, John C 75 1993~2020 39 122 华盛顿大学 美国
12 Williams, Julie 75 1996~2020 36 118 卡迪夫大学 英国
13 Amouyel, Philippe 74 1997~2019 36 108 里尔大学 法国
14 Lovestone, Simon 74 1996~2020 36 118 牛津大学 英国
15 Lambert, Jean Charles 73 1997~2019 36 111 里尔大学 法国
16 Tanzi, Rudolph E 73 1992~2020 41 148 哈佛大学 美国
17 Bennett, David A 72 2001~2020 32 65 拉什大学 美国
18 Sorbi, Sandro 72 1996~2020 31 71 佛罗伦萨大学 意大利
19 Soininen, Hilkka 70 1996~2019 31 92 东芬兰大学 芬兰
20 Cruchaga, Carlos 67 2009~2020 33 107 华盛顿大学 美国
Table 1 TOP20 authors of Alzheimer’s gene research
Fig.3 TOP20 author cooperation in Alzheimer’s disease gene research
Fig.4 TOP20 institutions in Alzheimer’s disease gene research
Fig.5 Institutions cooperation in Alzheimer’s disease gene research
国别 发文数量 占总发文
之比		 发文时间 合作国家
数量		 篇均合作国家
数量		 合作最多的国家
与文章数量
美国 2 582 40.60% 1991~2020 65 0.025 英国,265
中国 946 14.90% 1997~2020 31 0.033 美国,159
英国 523 8.21% 1992~2020 54 0.103 美国,265
意大利 532 8% 1991~2020 38 0.071 美国,92
德国 444 7% 1993~2020 45 0.101 美国,124
日本 414 6.50% 1991~2020 36 0.087 美国,93
西班牙 341 5.36% 1993~2020 38 0.111 美国,65
加拿大 326 5.12% 1991~2020 40 0.123 美国,147
法国 287 4.50% 1991~2020 43 0.15 英国,87
澳大利亚 248 3.90% 1996~2020 44 0.177 美国,71
Table 2 TOP10 countries in Alzheimer’s disease gene research
Fig.6 Publication Number of TOP10 countries in Alzheimer’s disease gene research in the past 10 years
Fig.7 Countries cooperation in Alzheimer’s disease gene research
Fig.8 Co-occurrence analysis of author keywords in Alzheimer’s disease gene research
[1]   Alzheimer A. Uber eine eigenartige erkrankung der hirnrinde. Allgemeine Zeitschrift fur Psychiatrie und phy- chish-Gerichtliche Medizin (Berlin), 1907,64:146-148.
[2]   Monaco A, Amoroso N, Bellantuono L, et al. Shannon entropy approach reveals relevant genes in alzheimer’s disease. PLoS One, 2019; 14(12):e0226190.
pmid: 31891941
[3]   Zawia N H, Lahiri D K, Cardozo-Pelaez F. Epigenetics, oxidative stress, and alzheimer disease. Free Radical Biology and Medicine, 2009,46(9):1241-1249.
doi: 10.1016/j.freeradbiomed.2009.02.006 pmid: 19245828
[4]   Muller W E, Eckert A, Kurz C, et al. Mitochondrial dysfunction: common final pathway in brain aging and alzheimer’s disease-therapeutic aspects. Molecular Neurobiology, 2010,41(2-3):159-171.
doi: 10.1007/s12035-010-8141-5 pmid: 20461558
[5]   Wakabayashi T, Yamaguchi K, Matsui K, et al. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of alzheimer’s disease. Molecular Neurodegeneration, 2019,14(15):1-18.
doi: 10.1186/s13024-018-0301-5
[6]   Rana P, Franco E F, Rao Y, et al. Evaluation of the common molecular basis in alzheimer’s and parkinson’s diseases. International Journal of Molecular Sciences, 2019,20(15):3730.
doi: 10.3390/ijms20153730
[7]   Herrera-Espejo S, Santos-Zorrozua B, Alvarez-Gonzalez P.. et al. A systematic review of microrna expression as biomarker of late-onset alzheimer’s disease. Molecular Neurobiology, 2019,56(12):8376-8391.
doi: 10.1007/s12035-019-01676-9 pmid: 31240600
[8]   Sims R, Hill M, Williams J. The multiplex model of the genetics of alzheimer’s disease. Nature Neuroscience, 2020,23(3):311-322.
pmid: 32112059
[9]   Nacmias B, Tedde A, Cellini E, et al. Alpha 2-macroglobulin polymorphisms in italian sporadic and familial alzheimer’s disease. Neuroscience Letters, 2001,299(1-2):9-12.
pmid: 11166925
[10]   Wavrant-De Vrieze F, Compton D, Womick M, et al. Abca1 polymorphisms and alzheimer’s disease. Neuroscience Letters, 2007,416(2):180-183.
doi: 10.1016/j.neulet.2007.02.010 pmid: 17324514
[11]   Mentis A F A, Dardiotis E, Chrousos G P. Apolipoprotein e4 and meningeal lymphatics in alzheimer disease: a conceptual framework. Molecular Psychiatry, 2020, doi: 10.1038/s41380-020-0731-7.
doi: 10.1038/s41380-020-0731-7 pmid: 33070149
[12]   Yuan Q, Wang F, Xue SF. et al. Association of polymorphisms in the lrp1 and a2m genes with alzheimer’s disease in the northern chinese han population. Journal of Clinical Neuroscience, 2013,20(2):247-250.
[13]   Van Uden E, Kang D E, Hoo E H, et al. Ldl receptor-related protein (lrp) in alzheimer’s disease: towards a unified theory of pathogenesis. Microscopy Research and Technique, 2000,50(4):268-272.
doi: 10.1002/1097-0029(20000815)50:4<268::AID-JEMT3>3.0.CO;2-1 pmid: 10936878
[14]   Munshi A, Ahuja Y R. Genes associated with alzheimer disease. Neurology Asia, 2010,15(2):109-118.
[15]   Lonneborg A. Biomarkers for alzheimer disease in cerebrospinal fluid, urine, and blood. Molecular Diagnosis & Therapy, 2008,12(5):307-320.
pmid: 18803429
[16]   Misra A, Chakrabarti S S, Gambhir I S. New genetic players in late-onset alzheimer’s disease: findings of genome-wide association studies. Indian Journal of Medical Research, 2018,148(2):135-144.
doi: 10.4103/ijmr.IJMR_473_17 pmid: 30381536
[17]   Carrasquillo M M, Belbin O, Hunter T A. et al. Replication of bin1 association with alzheimer’s disease and evaluation of genetic interactions. Journal of Alzheimers Disease, 2011,24(4):751-758.
[18]   Rohn T T. The triggering receptor expressed on myeloid cells 2: “Trem-ming” the inflammatory component associated with alzheimer’s disease. Oxidative Medicine and Cellular Longevity, 2013,2013:1-8.
[19]   Lambert J C, Heath S, Even G, et al. Genome-wide association study identifies variants at clu and cr1 associated with alzheimer’s disease. Nature Genetics, 2009,41(10):1094-U1068.
doi: 10.1038/ng.439 pmid: 19734903
[20]   Ray M, Zhang W X. Analysis of alzheimer’s disease severity across brain regions by topological analysis of gene co-expression networks. Bmc Systems Biology, 2010,4:136.
doi: 10.1186/1752-0509-4-136 pmid: 20925940
[21]   Ham S, Kim T K, Ryu J, et al. Comprehensive micrornaome analysis of the relationship between alzheimer disease and cancer in psen double-knockout mice. International Neurourology Journal, 2018,22(4):237-245.
doi: 10.5213/inj.1836274.137 pmid: 30599494
[22]   Checler F. Presenilins: multifunctional proteins involved in alzheimer’s disease pathology. Lubmb Life, 1999,48(1):33-39.
doi: 10.1080/713803480 pmid: 10791913
[23]   Senanarong V, An S S A, Giau V V. et al. Pathogenic psen1 glu184gly mutation in a family from thailand with probable autosomal dominant early onset alzheimer’s disease. Diagnostics, 2020,10(3):135.
[1] MA Li-li,YI Pan-pan,AO Ni-hua,JIAO Hong-tao,LEI Rui-peng,LIU Huan. A Study of Interdisciplinarity in Biosafety Research Based on Discipline Categories and Enrichment Analysis[J]. China Biotechnology, 2021, 41(12): 116-124.
[2] FAN Fu, CHEN Jian-guo, REN Hong-wei. Development of Gene Therapy for Parkinson’s Disease And Alzheimer’s Disease[J]. China Biotechnology, 2013, 33(4): 129-135.
主管：中国科学院 　主办：中国科学院文献情报中心 　中国生物技术发展中心 　中国生物工程学会